EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
BioLineRx Ltd. (BLRX) had EBITDA Margin of -827.46% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.18M |
|
$-1.18M |
|
$0.23M |
|
$0.95M |
|
$11.47M |
|
$-10.29M |
|
$8.26M |
|
$-2.03M |
|
$-2.03M |
|
$-2.03M |
|
$-2.03M |
|
$-2.03M |
|
$-2.03M |
|
$-10.29M |
|
$-9.76M |
|
4.11M |
|
4.11M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$23.68M |
|
$0.16M |
|
$17.22M |
|
$40.91M |
|
$12.12M |
|
$4.46M |
|
$5.44M |
|
$17.56M |
|
$23.34M |
|
$6.98M |
|
$23.34M |
|
2.61M |
|
| Cash Flow Statement Financials | |
$-8.07M |
|
$-8.54M |
|
$8.88M |
|
$10.44M |
|
$3.25M |
|
$-7.19M |
|
$0.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.95 |
|
-- |
|
-- |
|
0.16 |
|
0.38 |
|
80.51% |
|
-871.78% |
|
-871.78% |
|
|
EBITDA Margin |
-827.46% |
-171.69% |
|
-99.58% |
|
$-8.10M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.11 |
|
2.59 |
|
141.05 |
|
-8.68% |
|
-29.04% |
|
-4.95% |
|
-7.29% |
|
$8.94 |
|
$-1.97 |
|
$-1.97 |
|